Chesapeake's a Slee...
Health Care: Drugs
BioTime Inc. (BTIM: AMEX)
$5.63 -0.07 | -1.23%
07/29/10 - 03:59 PM ET
104.21K / 257.40K
Vol / Avg. Vol:5.75 / 5.70
Open / Prev. Close:5.52 - 5.78
Today's Range:3.01 - 8.42
52 Wk Range:33.10%
Performance YTD:TheStreet Rating:
Portfolios with BTIM
- Portfolio NameUser Type
- UserNest Egg Investing
- UserManielse's Holdings
- Userpetekni Portfolio 1
- UserScott Seeger Simon
Latest BTIM Headlines from TheStreet
- Scientists cheer Obama's stem cell reversal 03.10.09 | 03:03 am
Press Releases for BTIM
- BioTime Announces Addition Of New Stem Cell Lines To Its Product Portfolio - Business Wire 07.21.10 | 12:07 pm
- BioTime, Inc. Provides Financial Information About Its Acquisition Of ES Cell International Pte Ltd. - Business Wire 07.19.10 | 10:07 am
- BioTime CEO Dr. Michael West To Present At The Agora Financial Investment Symposium 2010 - Business Wire 07.09.10 | 08:07 am
- BioTime Announces Passing Of Board Director Dr. Robert N. Butler - Business Wire 07.06.10 | 06:07 pm
- BioTime Commences Warrant Discount Offer - Business Wire 06.18.10 | 10:06 am
- BioTime Announces Results Of Vote At Annual Shareholders Meeting - Business Wire 06.14.10 | 04:06 pm
- BioTime Set To Join Russell 3000 Index - Business Wire 06.13.10 | 03:06 pm
- BioTime Forms New Subsidiary, OrthoCyte Corporation, To Develop Treatments For Orthopedic Conditions Using Stem Cell Technology - Business Wire 06.10.10 | 03:06 pm
- BioTime CEO Dr. Michael West To Present At The Inaugural Jefferies Global Life Sciences Conference - Business Wire 06.08.10 | 07:06 pm
- BioTime Adds Five New Stem Cell Lines To Its Product Portfolio - Business Wire 05.27.10 | 08:05 am
